Wednesday, May 10, 2017

Great Point Partners Exits Professional Physical Therapy Investment

Great Point Partners, a health care investment firm headquartered in Greenwich, Connecticut, exited its investment with Professional Physical Therapy (ProPT), a private equity portfolio company, in December 2016. ProPT provides outpatient physical therapy service in New York, New Jersey, and Connecticut. Great Point Partners invested in the company in 2011.

At the time of the investment, ProPT operated in one state with 10 facilities and around 300 employees. GPP then helped ProPT develop its acquisition and integration platform, putting in place a board of directors that guided and strengthened the management team as it achieved an more than 35 percent compound annual growth rate.

During the partnership, 21 tuck-in acquisitions were executed. ProPT now provides its services through substantially more facilities in the New York, New Jersey, Connecticut Tri-State area, employing more than 1,200 individuals. This was the fourth exit for Great Point Partners since September 2015.

Friday, April 28, 2017

Clinical Supplies Management Acquires Two European Companies

A private equity investor based in Greenwich, Connecticut, Great Point Partners has invested into more than 100 businesses in the public and private healthcare sector since 2003. Through December 2016 and January 2017, the private equity portfolio company Clinical Supplies Management (CSM) completed the acquisition of two companies that will expand its range of services in Europe.

Theorem Clinical Supply (TCS) was the first of these acquisitions. A Frankfurt-based company that offers clinical trial drug labeling, storage, packaging, and distribution, TCS’ services extend throughout Western Europe. The acquisition, which it completed in December 2016, enables CSM to provide significantly improved services to its global clients.

The TCS acquisition was complemented by the acquisition of Brussel’s B&C Group in January 2017. B&C provides a range of clinical trial supplies, in addition to biomedical sample services, via its custom system architecture, which CSM aims to leverage to serve the needs of its pharmaceutical clients in both Europe and the United States.

Tuesday, April 18, 2017

Great Point Partners’ Sale of Equian

Maintaining an investment portfolio with portfolio companies primarily domiciled in the United States, Greenwich, Connecticut investment firm Great Point Partners (GPP) focuses primarily on health care companies. Among the firms Great Point Partners has invested in is Equian, which it sold in December 2015 to New Mountain Capital, LLC.

A leading payment integrity solutions provider that offers services to medical claims payers, Equian became a Great Point Partner's portfolio company in 2007. In the eight years that Great Point Partner's and Equian worked together, Equian achieved and exceeded the market positioning and corporate growth goals that its co-founders John Ansay and Russ Sherlock set for the firm.

In speaking about the sale that was achieved in December 2015 to New Mountain Capital, Great Point Partners’s principal Noah F. Rhodes III noted during GPP's investment period Equian had 11 add-on acquisitions and a strong annual earnings growth rate.

Friday, March 10, 2017

The GPP I and BMVF Funds

Headquartered in Connecticut, Great Point Partners is an investment management firm that specializes in the healthcare industry. Great Point Partners (GPP) was founded in 2003 and has invested in more than 100 healthcare businesses. 

The firm operates two separate divisions – one that focuses on private companies and one on public companies. 

Hedge funds are a limited partnership of investors that make investments. One type of hedge fund is the equity long/short hedge fund. Long/short hedge funds invest in the stock market buy buying and selling stocks.

Wednesday, March 1, 2017

Clinical Supplies Management Begins European Expansion

Great Point Partners is a Greenwich, Connecticut-based investment firm that targets both the public and private health care sectors. For over a decade, Great Point Partners has invested in firms that are advancing the quality and accessibility of innovative health care products. 

A recent growth recapitalization facilitated by GPP has allowed Clinical Supplies Management (CSM), a provider of clinical trial services and solutions, to expand its offerings across the Atlantic Ocean. In December 2016, the company announced the acquisition of Theorem Clinical Research-Clinical Supplies (TCS), a German clinical services firm. Headquartered in Frankfurt, the former Chiltern International subsidiary provides services for the full clinical life cycle, including packaging, reconciliation, and distribution. Its inclusion within CSM’s growing portfolio will greatly enhance the firm’s ability to serve clients throughout western Europe. 

The new partnership between CSM and the Theorem team not only will allow CSM to increase its European presence, but also provides TCS with a gateway to North American clinical clients and resources. Following the acquisition, TCS executive director RĂ¼diger Weber will draw on his expertise in the sector to head the bourgeoning European operations of CSM.

Tuesday, January 31, 2017

The Biotronic NeuroNetwork Mission

Located in Greenwich, Connecticut, Great Point Partners was founded with the goal of investing in growing businesses in the health care field. In September 2015, Great Point Partners portfolio company Biotronic NeuroNetwork completed the acquisition of Neurowave Monitoring, marking its seventh tuck-in acquisition under the supervision of GPP.

This acquisition took Biotronic’s mission of providing the highest quality intraoperative neural monitoring services a step forward. It aims for constant improvement with a team of experienced professionals, along with the support of a quality-assurance program. The overall vision is to offer a range of service that establishes Biotronic NeuroNetwork as a lead provider in the sector. It does this by supporting a patient-centric focus and investing in clinical trials, research, and continued education.

The acquisition of Neurowave Monitoring has allowed Biotronic to continue its growth throughout Southern California while also granting it access to a team of technologists that can help the company further its vision.